Henry Schein (NASDAQ:HSIC – Free Report) had its price target lifted by Jefferies Financial Group from $77.00 to $80.00 in a research note published on Thursday,Benzinga reports. The brokerage currently has a hold rating on the stock.
Several other equities research analysts have also recently commented on the company. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Evercore ISI raised their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Finally, Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Seven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $79.30.
Check Out Our Latest Stock Report on Henry Schein
Henry Schein Stock Down 0.0 %
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period in the previous year, the business earned $1.32 EPS. The firm’s revenue for the quarter was up .4% on a year-over-year basis. On average, analysts anticipate that Henry Schein will post 4.78 EPS for the current fiscal year.
Insider Activity at Henry Schein
In related news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.14% of the stock is owned by company insiders.
Hedge Funds Weigh In On Henry Schein
A number of hedge funds have recently modified their holdings of HSIC. Cibc World Market Inc. lifted its stake in shares of Henry Schein by 2.8% during the 4th quarter. Cibc World Market Inc. now owns 360,018 shares of the company’s stock valued at $24,913,000 after buying an additional 9,954 shares in the last quarter. Robeco Institutional Asset Management B.V. bought a new stake in Henry Schein during the fourth quarter valued at about $763,000. Olstein Capital Management L.P. lifted its position in shares of Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after acquiring an additional 16,000 shares in the last quarter. Fifth Third Bancorp boosted its stake in shares of Henry Schein by 11.0% in the fourth quarter. Fifth Third Bancorp now owns 3,366 shares of the company’s stock worth $233,000 after acquiring an additional 333 shares during the period. Finally, Merit Financial Group LLC grew its position in shares of Henry Schein by 15.8% during the fourth quarter. Merit Financial Group LLC now owns 23,137 shares of the company’s stock worth $1,601,000 after purchasing an additional 3,156 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles
- Five stocks we like better than Henry Schein
- How to Invest in Insurance Companies: A Guide
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- What Are the U.K. Market Holidays? How to Invest and Trade
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Where to Find Earnings Call Transcripts
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.